Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Comment by Apollo2014on Feb 22, 2021 3:57pm
131 Views
Post# 32629041

RE:RE:RE:Pull Back..

RE:RE:RE:Pull Back..Due diligence will show that the 2018 pop may have been in direct correlation to very positive supportive comments made by Rob McWhirter on BNN during that period in February 2018 where the stock jumped to .285 cents.  Volume during that period of peak rise clustered between 4-8 million daily.  The way it rose in 2018 was, in my opinion, quite dangerous due to abnormal high volume and many jumping into MDX over pure hype and speculation.  The difference this time around for us in 2021 is that the rise to where we are now has been gradual, balance, and not reckless accumulation.  Also, we have news to look forward to involving the second tranche and possible information regarding a chain pharmacy roll out that has been discussed.  This rise in sp, to me, is very different from the rise in 2018. 
<< Previous
Bullboard Posts
Next >>